Identification and analysis of relevant attributes for choices for liver cancer therapies.

Recruiting

• Conditions: C22.9; C78.7; C24.9; Liver, unspecified; Secondary malignant neoplasm of liver and intrahepatic bile duct; Biliary tract, unspecified

• Registration Number: DRKS00013304
• Lead Sponsor: Medizinische Hochschule Hannover

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1029

Inclusion Criteria

The study includes full aged liver cancer patients from Hannover Medical School who undergo a minimal invasive therapy e.g. thermal ablation, selective chemotherapy/radiotherapy, and surgical treatment. Moreover, we interview physicians stationed in the gastroenterology and medical nonprofessionals

Exclusion Criteria

Underage persons, critically ill and unstable patients, and patients who have participated in another study within the last 30 days are excluded from the study. Another exclusion criterion is to terminate the survey upon request. In order to determine the eligibility of a patient, the treating physician will ensure the examination of the medical exclusion criteria.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The main study aims to reveal the patients’ preferences for specific treatment options that, if medically justified, might be taken into account in future decision-making processes by medical professionals. The results can improve medical treatment in terms of evidence-based medicine and shared decision-making, and thereby increase the satisfaction (welfare) of both patients and physicians.<br>

Secondary Outcome Measures

Name	Time	Method
The aim of the preliminary study is to identify the relevant attributes of liver cancer therapies influencing the choice of therapy.